Erin L Symonds, Susanne Pedersen, David Murray, Graeme P Young. Circulating tumor DNA before and after resection for colorectal cancer. Presented at ASCO Annual, 2017

Erin L Symonds, Susanne Pedersen, Rohan Baker, Scott Mansfield, Dawn Bastin and Graeme P Young. The relationship between the degree of aberrant methylation in colorectal cancer tissue and appearance of tumor-derived DNA in blood. Presented at ASCO GI Symposium, 2017

Erin L Symonds, Susanne Pedersen, David Murray, Rohan Baker and Graeme P Young. Predictors of circulating tumor-derived methylated BCAT1 and IKZF1 DNA in colorectal cancer patients. Presented at ASCO GI Symposium, 2017

Erin L Symonds, Rohan Baker, Dawn Bastin, Libby Bambacas, Susie Byrne, Graeme P Young and Susanne Pedersen. Methylated BCAT1 and IKZF1 DNA in tissue and plasma from colorectal cancer cases. Presented at ASCO GI Symposium, 2016

Susanne Pedersen, Erin L Symonds, Scott Mansfield, Susan Byrne, Libby Bambacas, Paul Hollington, David Murray, Rohan Baker, Lawrence LaPointe, and Graeme P Young. A novel 2-gene blood test for colorectal cancer recurrence. Presented at ASCO GI Symposium, 2016

Rohan T. Baker, Snigdha Gaur, David Murray, Aidan McEvoy, Graeme Young, Lawrence LaPointe, and Susanne K. Pedersen. Detection of variable methylation patterns improves sensitivity of a colorectal cancer blood test. Presented at Digestive Disease Week, Washington DC, 2015

EL Symonds, S Pedersen, SR Cole, D Murray, J Massolino, D Byrne, J Guy, P Backhouse, RJ Fraser, L LaPointe, GP Young. Improving participation rates in community-based colorectal cancer screening - role of a blood test. Presented at Digestive Disease Week, Washington DC, 2015

EL Symonds, S Mansfield, D Mangira, D Murray, R Baker, S Pedersen, L LaPointe, GP Young. Methylated BCAT1 and IKZF1 DNA in plasma as novel biomarkers for colorectal cancer recurrence. Presented at Digestive Disease Week, Washington DC, 2015

EL Symonds, GP Young, JM Osborne, SR Cole, G Gopalsamy, S Gaur, D Murray, R Baker, L LaPointe, S Pedersen. Comparison of a methylated two-gene (BCAT1-IKZF1) blood test to FIT for detection of colorectal neoplasia. Presented at Digestive Disease Week, Washington DC, 2015

Dileep Mangira, Erin L Symonds, Graeme P Young, Stephen R Cole, Libby Bambacas, David Murray, Rohan T Baker, Lawrence C LaPointe, Susanne K Pedersen. The morphological features of colorectal tumors that are associated with the appearance of methylated DNA in plasma. Presented at Digestive Disease Week, Washington DC, 2015

Asia-Pacific Journal of Clinical Oncology, Vol. 10, Issue Suppl. S9, p211-212. DOI: 10.1111/ajco.12332

RT Baker, S Gaur, D Murray, A McEvoy, GP Young, LC LaPointe, SK Pedersen. Detection of variable methylation patterns improves colorectal cancer blood test sensitivity. Presented at AGW October 2014

EL Symonds, SK Pedersen, JM Osborne, G Gopalsamy, S Gaur, D Murray, A McEvoy, R Baker, SR Cole, LC LaPointe, GP Young. A methylated DNA blood test for colorectal cancer screening returns a lower false positivity rate than a faecal immunochemical test in people with benign bleeding conditions. Presented at AGW October 2014

D Mangira, GP Young, L Bambacas, EL Symonds, SR Cole, D Murray, R Baker, L LaPointe, S Pedersen. Appearance of tumor-associated methylated DNA in plasma correlates with colorectal tumour invasion. Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, SA, Australia, Clinical Genomics, North Ryde, NSW, Australia.  Accepted for Poster Presentation. Presenter: Dileep Mangira

Rohan T. Baker, David Murray, Sean Kearney, Lawrence LaPointe, and Susanne K. Pedersen. Method validation of a laboratory–developed blood test for colorectal cancer. Combio2014 Conference, Canberra, Australia. September 2014

G. Young. Evaluation of a 2-gene (IKZF1 and BCAT1) DNA blood test for detection of colorectal cancer. Digestive Disease Week, Chicago 2014. Abstract: Gastroenterology 2014;79(5) Suppl AB125

Redwood D, Provost E, Asay E, Roberts D, Haverkamp D, Perdue D, et al. Comparison of Fecal Occult Blood Tests for Colorectal Cancer Screening in an Alaska Native Population With High Prevalence of Helicobacter pylori Infection, 2008-2012. Prev Chronic Dis 2014;11:130281

Mitchell S, Ross JP, Drew H, Ho T, Brown G, Saunders N, Duesing K, Buckley M, Dunne R, Beeston I, Rand K, McEvoy A, Thomas M, Baker R, Wattchow D, Young GP, Lockett T, Pedersen S, LaPointe L, Molloy P. Colorectal cancer methylation biomarkers. 2014 Keystone Symposia Conference, Cancer Epigenetics, February 7, 2014

Baker R, Pedersen S, McEvoy A, Thomas M, Murray D, Molloy P, Young GP, LaPointe L. Clinical evaluation of a novel duplexed 2-gene DNA methylation blood test for colorectal cancer. Lorne Genome Conference, 2013, Lorne, Australia

Baker R, Pedersen S, McEvoy A, Thomas M, Murray D, Molloy P, Young GP, LaPointe L. Clinical evaluation of a novel duplexed 2-gene DNA methylation blood test for colorectal cancer. Lorne Genome Conference, 2013, Lorne, Australia

Rand K, Mitchell S, Molloy P, Pedersen S, LaPointe L, Young GP. Development of non-bisulphite-based assays for colorectal cancer DNA methylation markers. Gordon Research Conference, Cancer Genetics & Epigenetics, 2013 Italy

S. Pedersen. Novel methylation DNA biomarkers for colorectal neoplasia: From tissue to blood.  WEO Colorectal Cancer Screening Committee Meeting. May 18, 2012, San Diego

S. Pedersen. Discovery and validation of a novel DNA methylation biomarker for colorectal cancer with application to blood testing.  Digestive Disease Week. May 19, 2012, San Diego. Abstract: Gastroenterology 2012;142(5): Suppl 1, S33

Baker R, Pedersen S, McEvoy A, Thomas M, Murray D, Mitchell S, Molloy P, Young GP, LaPointe LC. Clinical Evaluation of a novel 2-gene methylation blood test for colorectal cancer. Australian Gastroenterology week 2012, Adelaide, Sydney

Baker R, Pedersen S, McEvoy A, Thomas M, Murray D, Mitchell S, Molloy P, Young GP, LaPointe LC. Clinical Evaluation of a novel 2-gene methylation blood test for colorectal cancer. Australian Gastroenterology Week 2012, Adelaide, Sydney

Thomas M, Pedersen S, McEvoy A, Vizgoft E, Gaur S, Beeston I, LaPointe L. Plasma Testing of Gene Expression Biomarkers for Colorectal Neoplasia discovered in Neoplastic Colorectal Tissue. Digestive Disease Week (AGA), Chicago USA 2011

LaPointe L, Dunne R, Molloy P, Clark L, Ho T, Pedersen S, Young G. Biomarkers with high sensitivity and specificity for colorectal adenomas and carcinomas. Digestive Disease Week (AGA), Chicago USA 2009

Pedersen S, Brown G, Graham L, Dunne R, Molloy P, Clark L, Young G, LaPointe L. A novel colorectal neoplasia gene (CRNG) with high sensitivity and specificity for both adenomas and carcinomas. Digestive Disease Week (AGA), Chicago USA 2009

Pedersen S, Richards E, McEvoy A, Dunne R, Brown G, Clark L, Young G, LaPointe L. Alternative splicing of S100A11 in colorectal adenomas and carcinomas. Digestive Disease Week (AGA), Chicago USA 2009

Moynihan A, Molloy P, Papangelis V, Young G, LaPointe L. Upregulation of mesolthelin, RegIV, and transcobalamin in colon adenomas and cancer. Digestive Disease Week (AGA), Chicago USA 2009

Wilson B, Phatak A, LaPointe L. Associative gene networks from microarray data in the normal colon. CSIRO Mathematical and Informational Sciences Annual Divisional Conference. Leura, NSW, Australia, 2006

LaPointe L, Dunne R, Worthely D, Molloy P, Wattchow D, Young G. Mapping gene expression along the anterior-posterior axis of the adult human colon. Digestive Disease Week (AGA), Los Angeles, USA, 2006

LaPointe L, Worthely D, Dunne R. Comparison of classification methodologies to discover biomarkers from gene expression data. Australian Microarrays Conference (AMATA). Barossa Valley, Australia 2005

Kiiveri H, Dunne R, LaPointe L. Canonical Variate Analysis and Microarrays. Australian Microarrays Conference (AMATA), Barossa, Australia 2005

LaPointe L, Dunne R. Comparison of machine learning techniques to identify biomarkers for colorectal cancer in publicly available data. International Society of Computational Biology, Detroit, Michigan, USA 2005

LaPointe L, Dunne R. Identification of colorectal cancer biomarkers using publicly available gene expression data. Digestive Disease Week (AGA), Chicago, USA 2005

Young G, Smith A, Cole S, Morcom J, LaPointe L, Chandler H. A quantifiable fecal immunochemical test (FIT) for hemoglobin facilitates balancing sensitivity with specificity when screening for colorectal cancer. European Gastroenterology Week, Prague, 2004

Smith A, Cole SR, Young GP, Morcom J, LaPointe L, Chandler H. A quantifiable faecal immunochemical test (FIT) for haemoglobin balancing sensitivity with specificity when screening for colorectal cancer. J. Gastro Hepatology 19(Suppl): A195, 2004

Smith A, Young GP, Cole SR, Morcom J, Chandler H, LaPointe L. A quantifiable faecal immunochemical test (FIT) for haemoglobin balancing sensitivity with specificity when screening for colorectal cancer. Gastroenterology 126(Suppl), 2004

LaPointe L, Young G, Chandler H. Analysis of mRNA expression profiles in colorectal adenomas using k-nearest neighbor cluster analysis. Digestive Disease Week (AGA), Orlando, USA 2003

LaPointe L, Bruce B, Roy M, Chandler H. Selecting for diagnostic colonoscopy by quantifiable fecal immunochemical tests. Gastroenterology, Supplement to 124(4), 2003

Sinatra MA, Bielecky B, Young GP, St John DJB, LaPointe L, Chandler H. Faecal hemoglobin measurement in colorectal neoplasia. J Gastro Hepatology, Supplement to 15, 2000